Ethermed Raises $8.5M Series A

Ethermed Raises $8.5M Series A

Ethermed, a Philadelphia, PA-based healthcare technology company that builds AI-driven automation for prior authorization and medical-necessity workflows, has successfully raised $8.5 million in Series A funding. This latest round brings Ethermed's total funding to over $15 million.

The Series A round was co-led by Enfield Capital Partners, a private equity and investment firm leveraging a “founders for founders” philosophy with a diversified portfolio, and Blue Marlin Partners, a Bethesda-based private equity firm operating through a deal-by-deal investment model. Additional participation came from Jumpstart Ventures, Healthliant Ventures, Woodard Family Office, and Gaingels.

The capital raised will be used to further develop and expand Ethermed's AI-driven automation platform, which is designed to streamline prior authorization and medical-necessity workflows within the healthcare sector.

Ethermed is a healthcare technology company focused on addressing inefficiencies in healthcare administrative processes. The company builds AI-driven automation solutions specifically for prior authorization and medical-necessity workflows, aiming to enhance operational efficiency for healthcare providers.

Funding Details

Company: Ethermed

Raised: $8.5M

Round: Series A

Funding Date: April 20, 2026

Lead Investor: Enfield Capital Partners, Blue Marlin Partners

Additional Investors: Jumpstart Ventures, Healthliant Ventures, Woodard Family Office, Gaingels

Software Category: Healthcare IT, AI Automation

Company Website: https://ethermed.ai